Tempus AI Files for US IPO Touting ‘Intelligent Diagnostics’

Tempus AI Inc., a technology platform company using artificial intelligence to process medical data, filed for an initial public offering, joining a rush of companies going public while touting their AI credentials.

The company said in its filing Monday with the US Securities and Exchange Commission that it’s creating “intelligent diagnostics” for precision medicine. Tempus AI didn’t give details of the IPO such as the offer price, which will be included in future filings.

Chicago-based Tempus AI had a net loss of $266 million on revenue of $532 million in 2023, compared with a net loss of $334 ...